[EN] COMPOUND AS VOLTAGE-GATED SODIUM CHANNEL INHIBITOR [FR] COMPOSÉ UTILISÉ COMME INHIBITEUR DE CANAUX SODIQUES VOLTAGE-DÉPENDANTS [ZH] 用作电压-门控钠通道抑制剂的化合物
[EN] COMPOUND AS VOLTAGE-GATED SODIUM CHANNEL INHIBITOR [FR] COMPOSÉ UTILISÉ COMME INHIBITEUR DE CANAUX SODIQUES VOLTAGE-DÉPENDANTS [ZH] 用作电压-门控钠通道抑制剂的化合物
[EN] N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE<br/>[FR] DÉRIVÉS DE N- (PYRIDIN-2-YL) PYRIDINE-SULFONAMIDE ET LEUR UTILISATION DANS LE TRAITEMENT D'UNE MALADIE
申请人:NOVARTIS AG
公开号:WO2018042316A1
公开(公告)日:2018-03-08
The invention relates to heterocyclic compounds of the formula (I) in which all of the variables are as defined in the specification; capable of modulating the activity of CFTR. The invention further provides a method for manufacturing compounds of the invention, and its therapeutic uses. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including Cystic fibrosis and related disorders.
N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of disease
申请人:Novartis AG
公开号:US10450273B2
公开(公告)日:2019-10-22
The invention relates to heterocyclic compounds of the formula (I)
in which all of the variables are as defined in the specification; capable of modulating the activity of CFTR. The invention further provides a method for manufacturing compounds of the invention, and its therapeutic uses. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including Cystic fibrosis and related disorders.
N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE
申请人:Novartis AG
公开号:EP3504194B1
公开(公告)日:2021-08-18
N-(pyridin-2-yl)pyridine-sulfonamide Derivatives and their Use in the Treatment of Disease
申请人:Novartis AG
公开号:US20180072673A1
公开(公告)日:2018-03-15
The invention relates to heterocyclic compounds of the formula (I)
in which all of the variables are as defined in the specification; capable of modulating the activity of CFTR. The invention further provides a method for manufacturing compounds of the invention, and its therapeutic uses. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including Cystic fibrosis and related disorders.
[EN] COMPOUND AS VOLTAGE-GATED SODIUM CHANNEL INHIBITOR<br/>[FR] COMPOSÉ UTILISÉ COMME INHIBITEUR DE CANAUX SODIQUES VOLTAGE-DÉPENDANTS<br/>[ZH] 用作电压-门控钠通道抑制剂的化合物